Norlevo (Levonorgestrel)

Levonorgestrel, the active ingredient in Norlevo, is a progestogen presented as an oral tablet for oral use. The tablet is formulated for rapid absorption and is approved for emergency contraception. It is employed to prevent pregnancy after unprotected sexual intercourse in women of reproductive age and can be taken up to 72 hours after intercourse.

GNH USA supplies Norlevo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality through rigorous testing and provides global logistics support.

Norlevo (levonorgestrel) is used within the emergency contraception pathway to prevent unintended pregnancy.

- Emergency contraception: prevents pregnancy when taken within 72 hours after unprotected intercourse. - Contraceptive failure backup: provides a rescue option after a missed or ineffective regular hormonal contraceptive dose. - Post‑coital contraception: reduces the risk of implantation when administered promptly after sexual exposure.

Levonorgestrel may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Nausea - Headache - Fatigue - Breast tenderness

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Severe abdominal pain or persistent vomiting - Unusual vaginal bleeding

When using Norlevo, consider the following precautions to ensure safe and effective use.

- Timing of intake: take as soon as possible after unprotected intercourse, preferably within 72 hours. - Contraindications: avoid if there is a known hypersensitivity to levonorgestrel or any tablet excipients. - Medical conditions: use with caution in women with liver disease, hormonal disorders, or uncontrolled epilepsy. - Pregnancy testing: not required before use, but the product will not terminate an established pregnancy. - Drug interactions: be aware of enzyme‑inducing medications that may reduce efficacy. - Store at ambient temperature: keep below 25°C, retain in the original pack, and protect from moisture.

Levonorgestrel may interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Rifampicin, phenobarbital, carbamazepine, phenytoin: potent enzyme inducers that markedly reduce levonorgestrel plasma levels. - St. John's wort: herbal inducer that may lower effectiveness.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole): may increase levonorgestrel concentrations. - Protease inhibitor antiretrovirals: can alter metabolism, requiring clinical monitoring. - Combined hormonal contraceptives: additive progestogenic effect may increase side‑effect risk.